<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 23 Sep 2026 07:02:18 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Glaukos partners with Stephen Curry on keratoconus awareness campaign</title>
   <link>http://www.streetinsider.com/Corporate+News/Glaukos+partners+with+Stephen+Curry+on+keratoconus+awareness+campaign/27093213.html</link>
   <description>&lt;p&gt;Glaukos Corporation (NYSE: GKOS) has launched a disease awareness campaign called &quot;Could it be KC?&quot; in partnership with NBA player Stephen Curry, aimed at improving recognition and earlier detection of keratoconus, a progressive corneal disease.&lt;/p&gt;&lt;p&gt;Curry, who has been diagnosed with keratoconus, will share his personal experience with the condition as part of the campaign. &quot;For a long time, I got used to just getting by, squinting and brushing off headaches, without realizing anything was wrong with my eyes,&quot; Curry said. &quot;When I was diagnosed with keratoconus, it was scary, but I knew I couldn't ignore it and asked for help.&quot;&lt;/p&gt;&lt;p&gt;To</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Glaukos+partners+with+Stephen+Curry+on+keratoconus+awareness+campaign/27093213.html</guid>
   <pubDate>Wed, 23 Sep 2026 07:02:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Glaukos Partners with NBA Champion Stephen Curry to Launch “Could it be KC?” Campaign to Raise Awareness of Keratoconus</title>
   <link>http://www.streetinsider.com/Press+Releases/Glaukos+Partners+with+NBA+Champion+Stephen+Curry+to+Launch+%E2%80%9CCould+it+be+KC%3F%E2%80%9D+Campaign+to+Raise+Awareness+of+Keratoconus/27093127.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;New Campaign Aims to Raise Awareness, Educate Patients and Families, and Promote Earlier Detection and Diagnosis&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Curry to Share His Personal Journey Living with Keratoconus to Empower Individuals to Prioritize Proactive Eye Care and Recognize the Importance of Early Detection&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Could it be KC? Campaign and Curry Partnership Underscore Glaukos’ Commitment to Addressing Keratoconus Underdiagnosis and Undertreatment&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced the launch of &lt;i&gt;Could it be KC?&lt;/i&gt;, a new</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Glaukos+Partners+with+NBA+Champion+Stephen+Curry+to+Launch+%E2%80%9CCould+it+be+KC%3F%E2%80%9D+Campaign+to+Raise+Awareness+of+Keratoconus/27093127.html</guid>
   <pubDate>Wed, 23 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Glaukos Partners with NBA Champion Stephen Curry to Launch “Could it be KC?” Campaign to Raise Awareness of Keratoconus</title>
   <link>http://www.streetinsider.com/Business+Wire/Glaukos+Partners+with+NBA+Champion+Stephen+Curry+to+Launch+%E2%80%9CCould+it+be+KC%3F%E2%80%9D+Campaign+to+Raise+Awareness+of+Keratoconus/27093127.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;New Campaign Aims to Raise Awareness, Educate Patients and Families, and Promote Earlier Detection and Diagnosis&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Curry to Share His Personal Journey Living with Keratoconus to Empower Individuals to Prioritize Proactive Eye Care and Recognize the Importance of Early Detection&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Could it be KC? Campaign and Curry Partnership Underscore Glaukos’ Commitment to Addressing Keratoconus Underdiagnosis and Undertreatment&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced the launch of &lt;i&gt;Could it be KC?&lt;/i&gt;, a new</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Glaukos+Partners+with+NBA+Champion+Stephen+Curry+to+Launch+%E2%80%9CCould+it+be+KC%3F%E2%80%9D+Campaign+to+Raise+Awareness+of+Keratoconus/27093127.html</guid>
   <pubDate>Wed, 23 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Sep 16  Filed by: Navratil Tomas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Sep+16++Filed+by%3A+Navratil+Tomas/27081383.html</link>
   <description>si-local-file:///var/storage/secattach/20260918/27081383.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Sep+16++Filed+by%3A+Navratil+Tomas/27081383.html</guid>
   <pubDate>Fri, 18 Sep 2026 17:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Navratil Tomas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/27070493.html</link>
   <description>si-local-file:///var/storage/secattach/20260916/27070493.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/27070493.html</guid>
   <pubDate>Wed, 16 Sep 2026 16:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 28  Filed by: Navratil Tomas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+28++Filed+by%3A+Navratil+Tomas/27014132.html</link>
   <description>si-local-file:///var/storage/secattach/20260901/27014132.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+28++Filed+by%3A+Navratil+Tomas/27014132.html</guid>
   <pubDate>Tue, 01 Sep 2026 18:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Navratil Tomas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/26996516.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260828/A4Z2S22CZ222TJYZ25292ZZ2UUQLJK2SZ282&quot;&gt;http://archive.fast-edgar.com/20260828/A4Z2S22CZ222TJYZ25292ZZ2UUQLJK2SZ282&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: August 28, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/26996516.html</guid>
   <pubDate>Fri, 28 Aug 2026 13:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Navratil Tomas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/26996516.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260828/A4Z2S22CZ222TJYZ25292ZZ2UUQLJK2SZ282&quot;&gt;http://archive.fast-edgar.com/20260828/A4Z2S22CZ222TJYZ25292ZZ2UUQLJK2SZ282&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: August 28, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Navratil+Tomas/26996516.html</guid>
   <pubDate>Fri, 28 Aug 2026 13:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 19  Filed by: Kliman Gilbert H</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+19++Filed+by%3A+Kliman+Gilbert+H/26957524.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26957524.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+19++Filed+by%3A+Kliman+Gilbert+H/26957524.html</guid>
   <pubDate>Thu, 20 Aug 2026 20:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 19  Filed by: Kliman Gilbert H</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+19++Filed+by%3A+Kliman+Gilbert+H/26957524.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26957524.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+19++Filed+by%3A+Kliman+Gilbert+H/26957524.html</guid>
   <pubDate>Thu, 20 Aug 2026 20:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Kliman Gilbert H</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Kliman+Gilbert+H/26950359.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26950359.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Kliman+Gilbert+H/26950359.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Kliman Gilbert H</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Kliman+Gilbert+H/26950359.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26950359.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Kliman+Gilbert+H/26950359.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Glaukos Announces Participation in Wells Fargo Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</link>
   <description>
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA.

&lt;/p&gt;&lt;p&gt;
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Finvestors.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=http%3A%2F%2Finvestors.glaukos.com&amp;amp;index=1&amp;amp;md5=c35ac2a2fa1896d7a6c4fa6e35b00916&quot; shape=&quot;rect&quot;&gt;http://investors.glaukos.com&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;About Glaukos&lt;/b&gt;

&lt;/p&gt;&lt;p&gt;
Glaukos (&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=www.glaukos.com&amp;amp;index=2&amp;amp;md5=6ceae87db5ca65aa3a45ee77c813db0d&quot; shape=&quot;rect&quot;&gt;www.glaukos.com&lt;/a&gt;) is an ophthalmic pharmaceutical and medical technology company focused</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</guid>
   <pubDate>Wed, 19 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Glaukos Announces Participation in Wells Fargo Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</link>
   <description>
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA.

&lt;/p&gt;&lt;p&gt;
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Finvestors.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=http%3A%2F%2Finvestors.glaukos.com&amp;amp;index=1&amp;amp;md5=c35ac2a2fa1896d7a6c4fa6e35b00916&quot; shape=&quot;rect&quot;&gt;http://investors.glaukos.com&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;About Glaukos&lt;/b&gt;

&lt;/p&gt;&lt;p&gt;
Glaukos (&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=www.glaukos.com&amp;amp;index=2&amp;amp;md5=6ceae87db5ca65aa3a45ee77c813db0d&quot; shape=&quot;rect&quot;&gt;www.glaukos.com&lt;/a&gt;) is an ophthalmic pharmaceutical and medical technology company focused</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</guid>
   <pubDate>Wed, 19 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Glaukos Announces Participation in Wells Fargo Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</link>
   <description>
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA.

&lt;/p&gt;&lt;p&gt;
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Finvestors.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=http%3A%2F%2Finvestors.glaukos.com&amp;amp;index=1&amp;amp;md5=c35ac2a2fa1896d7a6c4fa6e35b00916&quot; shape=&quot;rect&quot;&gt;http://investors.glaukos.com&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;About Glaukos&lt;/b&gt;

&lt;/p&gt;&lt;p&gt;
Glaukos (&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=www.glaukos.com&amp;amp;index=2&amp;amp;md5=6ceae87db5ca65aa3a45ee77c813db0d&quot; shape=&quot;rect&quot;&gt;www.glaukos.com&lt;/a&gt;) is an ophthalmic pharmaceutical and medical technology company focused</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</guid>
   <pubDate>Wed, 19 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Glaukos Announces Participation in Wells Fargo Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</link>
   <description>
&lt;p&gt;    ALISO VIEJO, Calif.--(BUSINESS WIRE)--
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA.

&lt;/p&gt;&lt;p&gt;
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Finvestors.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=http%3A%2F%2Finvestors.glaukos.com&amp;amp;index=1&amp;amp;md5=c35ac2a2fa1896d7a6c4fa6e35b00916&quot; shape=&quot;rect&quot;&gt;http://investors.glaukos.com&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;About Glaukos&lt;/b&gt;

&lt;/p&gt;&lt;p&gt;
Glaukos (&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.glaukos.com&amp;amp;esheet=54590590&amp;amp;newsitemid=20260819707547&amp;amp;lan=en-US&amp;amp;anchor=www.glaukos.com&amp;amp;index=2&amp;amp;md5=6ceae87db5ca65aa3a45ee77c813db0d&quot; shape=&quot;rect&quot;&gt;www.glaukos.com&lt;/a&gt;) is an ophthalmic pharmaceutical and medical technology company focused</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Glaukos+Announces+Participation+in+Wells+Fargo+Healthcare+Conference/26947036.html</guid>
   <pubDate>Wed, 19 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 11  Filed by: Gilliam Joseph E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+11++Filed+by%3A+Gilliam+Joseph+E/26923166.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26923166.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+11++Filed+by%3A+Gilliam+Joseph+E/26923166.html</guid>
   <pubDate>Thu, 13 Aug 2026 19:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 11  Filed by: Gilliam Joseph E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+11++Filed+by%3A+Gilliam+Joseph+E/26923166.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26923166.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+11++Filed+by%3A+Gilliam+Joseph+E/26923166.html</guid>
   <pubDate>Thu, 13 Aug 2026 19:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 07  Filed by: Thurman Alex R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+07++Filed+by%3A+Thurman+Alex+R./26907252.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26907252.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+07++Filed+by%3A+Thurman+Alex+R./26907252.html</guid>
   <pubDate>Tue, 11 Aug 2026 17:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Aug 07  Filed by: Thurman Alex R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+07++Filed+by%3A+Thurman+Alex+R./26907252.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26907252.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Aug+07++Filed+by%3A+Thurman+Alex+R./26907252.html</guid>
   <pubDate>Tue, 11 Aug 2026 17:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Gilliam Joseph E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Gilliam+Joseph+E/26904056.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26904056.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Gilliam+Joseph+E/26904056.html</guid>
   <pubDate>Tue, 11 Aug 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Gilliam Joseph E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Gilliam+Joseph+E/26904056.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26904056.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Gilliam+Joseph+E/26904056.html</guid>
   <pubDate>Tue, 11 Aug 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Thurman Alex R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Thurman+Alex+R./26892369.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892369.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Thurman+Alex+R./26892369.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  144        GLAUKOS Corp                           Filed by: Thurman Alex R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Thurman+Alex+R./26892369.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892369.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++GLAUKOS+Corp+++++++++++++++++++++++++++Filed+by%3A+Thurman+Alex+R./26892369.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
  <item>
   <title>Form  4          GLAUKOS Corp              For: Jul 31  Filed by: WEN LEANA</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Jul+31++Filed+by%3A+WEN+LEANA/26858788.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26858788.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GLAUKOS+Corp++++++++++++++For%3A+Jul+31++Filed+by%3A+WEN+LEANA/26858788.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GKOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00859996</category>
   	  </item>
 </channel>
</rss>
